美瑞健康國際：年報 2023

Futu NewsApr 29 17:08 · Announcements

Merry Health International (02327.HK) received 1.8 million additional shares of common stock from Zhongjia U-Home Investment Limited, worth approximately HK$265,900

On April 29, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 29, Zhongjia U-Home Investment Limited increased its share holdings of $Merrill Health International (02327.HK) by $1.8 million at an average price of HK$0.1,477 per share on April 26, worth about HK$265,900. After the increase in holdings, Zhongjia U-Home Investment Limited's latest shareholding was 708 million shares, and the good position ratio increased from 17.25% to 17.29%. This transaction involves

Futu NewsApr 29 17:04

Merrill Health International (02327.HK) received 1.08 million additional shares of common stock from Zhongjia U-Home Investment Limited, worth approximately HK$149,700

On April 26, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 26, Zhongjia U-Home Investment Limited increased its share holdings of $Merrill Health International (02327.HK) by $1.08 million at an average price of HK$0.1,386 per share on April 25, worth about HK$149,700. After the increase in holdings, Zhongjia U-Home Investment Limited's latest shareholding was 706 million shares, and the good position ratio rose from 17.22% to 17.25%. This transaction involves

Futu NewsApr 26 17:02

四環醫藥：2023年度報告

Futu NewsApr 26 16:33 · Announcements

Sihuan Pharmaceutical (00460.HK): Three Mendon insulin series products developed by Huisheng Biotech have obtained the proposed selection criteria in the special continuous procurement of insulin

Gelonghui, April 25, 丨 Sihuan Pharmaceutical (00460.HK) announced that on April 23, 2024, Huisheng Biopharmaceutical Co., Ltd., a non-wholly-owned subsidiary of the Group, participated in the national centralized drug procurement (insulin special continuation) declaration work organized by the State Organization Drug Joint Procurement Office. The three products developed by Huisheng Biotech, Mendon Insulin 30 Injection, and Menton Insulin 50 Injection were eligible for selection in this special succession of insulin purchases, and they all plan to select Class A varieties. The current centralized insulin procurement cycle starts from the date of implementation of the selection results to 2027

Gelonghui FinanceApr 25 17:23

Merrill Health International (02327.HK) received 900,000 additional shares of common stock from Zhongjia U-Home Investment Limited, worth approximately HK$123,600

On April 25, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 25, Zhongjia U-Home Investment Limited increased its share holdings of $Merrill Health International (02327.HK) by $900,000 at an average price of HK$0.1373 per share on April 24, worth about HK$123,600. After the increase in holdings, Zhongjia U-Home Investment Limited's latest shareholding was 705 million shares, and the good position ratio increased from 17.20% to 17.22%. This transaction involves

Futu NewsApr 25 17:04